Hughes Thomas E.

Viridian Therapeutics, Inc.\de

Director

Avg. Two Year Performance

(86%) Avg. Purchase Return (36%) Compound

94% Avg. Sale Return 39% Compound

Holdings: 12.83K shares

Last Three Months: 25-Aug-24 -- 24-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Medical Laboratories & Research

Health Services

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions